Clinical Trial

A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

Name: A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections — clinical trial record (NCT06939829)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AVIATOR

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The objective of this study is to determine whether continuous infusion of ceftazidime-avibactam (CAZ-AVI) could improve clinical outcomes in critically ill patients compared with intermittent infusion.

Trial Details

NCT Number	NCT06939829
Lead Sponsor	Southeast University, China
Conditions	Patients With Critically Ill Infections
Enrollment	1,200 participants
Start Date	2025-05-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-23